文献速递垂体与肾上腺疾病

无功能性垂体腺瘤术后进展与否的全基因组DNA甲基化差异

Genome-wide DNA Methylation Differences in Nonfunctioning Pituitary Adenomas With and Without Postsurgical Progression.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

在大学医院开展的病例对照探索性试验中,比较术后肿瘤进展需再干预(n=26)与术后残留但至少5年影像学稳定(n=17)的无功能性垂体腺瘤患者肿瘤样本全基因组甲基化,发现605个CpG位点显著差异甲基化,映射至389个基因,部分位点与无再干预生存独立相关。

要点

  • 术后进展需再干预组与至少5年影像学稳定组间检出605个差异甲基化CpG位点,映射389个基因。
  • 差异甲基化位点最多的基因是NUP93和LGALS1。
  • P值最低的3个低甲基化和3个高甲基化位点均与无再干预生存独立相关,其中1个高甲基化位点位于GABRA1。

核心结论

  • 在这项探索性研究中,无功能性垂体腺瘤患者的DNA甲基化模式与术后需再干预的肿瘤进展相关,差异甲基化位点包含既往与肿瘤发生相关的基因。

研究设计与样本

  • 大学医院开展的病例对照探索性试验,研究对象为因无功能性垂体腺瘤接受手术且免疫组化具有促性腺激素瘤特征的患者。
  • 再干预组为因肿瘤进展需再干预的患者(n=26),对照组为术后有残留肿瘤但至少5年无肿瘤进展的影像学稳定组(n=17)。
  • 对每个肿瘤样本使用Infinium MethylationEPIC BeadChip平台分析全基因组甲基化数据。

主要发现

  • 两组间有605个CpG位点显著差异甲基化(错误发现率校正P值<0.05,beta值>0.2),映射至389个基因。
  • 差异甲基化位点数量最多的基因是NUP93和LGALS1。
  • P值最低的3个低甲基化差异甲基化位点和3个高甲基化差异甲基化位点均分别与无再干预生存显著相关(P<0.05)。
  • P值最低的高甲基化差异甲基化位点之一位于GABRA1基因。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Tumor progression in surgically treated patients with nonfunctioning pituitary adenomas (NFPAs) is associated with excess mortality. Reliable biomarkers allowing early identification of tumor progression are missing. OBJECTIVE: To explore DNA methylation patterns associated with tumor progression in NFPA patients. METHODS: This case-controlled exploratory trial at a university hospital studied patients who underwent surgery for NFPA that had immunohistochemical characteristics of a gonadotropinoma. Cases included patients requiring reintervention due to tumor progression (reintervention group, n = 26) and controls who had a postoperative residual tumor without tumor progression for at least 5 years (radiologically stable group, n = 17). Genome-wide methylation data from each tumor sample were analyzed using the Infinium MethylationEPIC BeadChip platform. RESULTS: The analysis showed that 605 CpG positions were significantly differently methylated (differently methylated positions, DMPs) between the patient groups (false discovery rate adjusted P value < 0.05, beta value > 0.2), mapping to 389 genes. The largest number of DMPs were detected in the genes NUP93 and LGALS1. The 3 hypomethylated DMPs and the 3 hypermethylated DMPs with the lowest P values were all significantly (P < 0.05) and individually associated with reintervention-free survival. One of the hypermethylated DMPs with the lowest P value was located in the gene GABRA1. CONCLUSION: In this exploratory study, DNA methylation patterns in NFPA patients were associated with postoperative tumor progression requiring reintervention. The DMPs included genes that have been previously associated with tumor development. Our study is a step toward finding epigenetic signatures to predict tumor progression in patients with NFPA.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Hallén T, Johannsson G, Dahlén R, et al. Genome-wide DNA Methylation Differences in Nonfunctioning Pituitary Adenomas With and Without Postsurgical Progression. J Clin Endocrinol Metab. 2022. PMID: 35485764. doi:10.1210/clinem/dgac266

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。